Unicycive Therapeutics Inc

Market Cap

$200M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$6.92+$1.12 (+19.31%)

Jun 5, 2026

52W High $9.0052W Low $3.74

Company Details

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosph...

CEO

—

IPO Date

Jul 12, 2021

Website

unicycive.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$40M

EPS (Diluted)

Free Cash Flow

-$29M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 12, 2026

FY 2025

Mar 30, 2026

Q4 2025

Mar 30, 2026

$0-100.0%

Q3 2025

Nov 12, 2025

Q2 2025

Aug 14, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee